Last Price$80.89NASDAQ Closing Price as of 4:00PM ET 2/21/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-1.88(2.27%)
Bid (Size)$79.21 (1)
Ask (Size)$81.37 (1)
Day Low / High$80.38 - 82.74
Volume1.4 M

Insider Trends: 90-Day Insider Buying Trend at Incyte Slowed with Sale of Shares

4:41PM ET 8/05/2019 MT Newswires
Jean Jacques Bienaime, Director, sold 1,724 shares in Incyte (INCY) on Aug 01, 2019, for $146,654. Bienaime, subsequent to the transactions designated in the SEC Form 4 filing, owns 7,055 shares of company stock, which have a market value of $588,881 as of the prior-day closing price.

Over the last 90 days, prior to the date of this filing, there have been 44 insider transactions reported to the SEC for Incyte. These transactions came from the activities of 15 separate insiders that resulted in a net acquisition of 67,915 company shares. This compares with the preceding 90-day window of time where there were 29 transactions from 15 insiders which resulted in the net acquisition of 118,393 shares.

This level of insider transactions is higher than the peer group average for the 207-company Biotechnology & Medical Research peer group over the last 90-day period. Activity in the peer group averaged 38.9 transactions per company, with company insiders acquiring on average 23,682 shares.

SEC Story Link